Skip to content
November 3, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
A Watershed Moment in Neurology: C2N Diagnostics’ PrecivityAD2 Cleared for Early Alzheimer’s Detection a-watershed-moment-in-neurology-c2n-diagnostics-precivityad2-cleared-for-early-alzheimers-detection
  • Treatment Innovations

A Watershed Moment in Neurology: C2N Diagnostics’ PrecivityAD2 Cleared for Early Alzheimer’s Detection

Asep Darmawan August 21, 2026
In a landmark development for the field of precision neurology, C2N Diagnostics has secured U.S. Food and...
Read More Read more about A Watershed Moment in Neurology: C2N Diagnostics’ PrecivityAD2 Cleared for Early Alzheimer’s Detection
Navigating the Uncharted: Empowering Children Through a Parent’s Cancer Diagnosis navigating-the-uncharted-empowering-children-through-a-parents-cancer-diagnosis
  • Patient Advocacy and Support

Navigating the Uncharted: Empowering Children Through a Parent’s Cancer Diagnosis

Azzam Bilal Chamdy August 21, 2026
By Kelsey Mora, CCLS, LCPC, Chief Clinical Officer at Pickles Group The words "you have cancer" can...
Read More Read more about Navigating the Uncharted: Empowering Children Through a Parent’s Cancer Diagnosis
Ending the Diagnostic Odyssey: Can Early Exome Sequencing Transform Clinical Care? ending-the-diagnostic-odyssey-can-early-exome-sequencing-transform-clinical-care-1
  • Genomics and Precision Medicine

Ending the Diagnostic Odyssey: Can Early Exome Sequencing Transform Clinical Care?

Pevita Pearce August 21, 2026
In the landscape of modern medicine, few challenges are as persistent or as emotionally taxing as the...
Read More Read more about Ending the Diagnostic Odyssey: Can Early Exome Sequencing Transform Clinical Care?
Navigating the Emotional Landscape: Understanding Your Child’s Response to a Cancer Diagnosis navigating-the-emotional-landscape-understanding-your-childs-response-to-a-cancer-diagnosis
  • Survivorship and Post-Treatment

Navigating the Emotional Landscape: Understanding Your Child’s Response to a Cancer Diagnosis

Rifan Muazin August 21, 2026
By Kelsey Mora, CCLS, LCPC Chief Clinical Officer at Pickles Group and author of The Dot Method...
Read More Read more about Navigating the Emotional Landscape: Understanding Your Child’s Response to a Cancer Diagnosis
AstraZeneca trips in PD-1 bispecific market after Phase III NSCLC failure astrazeneca-trips-in-pd-1-bispecific-market-after-phase-iii-nsclc-failure
  • Medical Research and Clinical Trials

AstraZeneca trips in PD-1 bispecific market after Phase III NSCLC failure

Azzam Bilal Chamdy August 21, 2026
To write a 1,200+ word news article with the specified structure (Main facts, Chronology, Supporting data, Official...
Read More Read more about AstraZeneca trips in PD-1 bispecific market after Phase III NSCLC failure
The Great GLP-1 Gold Rush: Lilly and Novo Nordisk Navigate a Shifting Obesity Market the-great-glp-1-gold-rush-lilly-and-novo-nordisk-navigate-a-shifting-obesity-market
  • Treatment Innovations

The Great GLP-1 Gold Rush: Lilly and Novo Nordisk Navigate a Shifting Obesity Market

Reynand Wu August 21, 2026
The pharmaceutical landscape is currently being reshaped by a singular, multibillion-dollar phenomenon: the race to dominate the...
Read More Read more about The Great GLP-1 Gold Rush: Lilly and Novo Nordisk Navigate a Shifting Obesity Market
Redefining the Standard of Care: Insights from the EMBARK Trial on High-Risk Biochemical Recurrence redefining-the-standard-of-care-insights-from-the-embark-trial-on-high-risk-biochemical-recurrence
  • Clinical Oncology Education

Redefining the Standard of Care: Insights from the EMBARK Trial on High-Risk Biochemical Recurrence

Asro August 21, 2026
In the rapidly evolving landscape of oncology, the management of prostate cancer—specifically cases marked by high-risk biochemical...
Read More Read more about Redefining the Standard of Care: Insights from the EMBARK Trial on High-Risk Biochemical Recurrence
The Biotech Gold Rush: Mapping the 50 Best-Funded Private Innovators of 2026 the-biotech-gold-rush-mapping-the-50-best-funded-private-innovators-of-2026
  • Chemotherapy and Targeted Therapy

The Biotech Gold Rush: Mapping the 50 Best-Funded Private Innovators of 2026

Lina Hope August 21, 2026
The biotechnology landscape in 2026 is defined by a paradox of caution and abundance. While the broader...
Read More Read more about The Biotech Gold Rush: Mapping the 50 Best-Funded Private Innovators of 2026
The Crisis of Confidence: Public Misinformation, Environmental Claims, and the Rise of AI-Generated Health Fraud the-crisis-of-confidence-public-misinformation-environmental-claims-and-the-rise-of-ai-generated-health-fraud
  • Breast Cancer Legislation and Policy

The Crisis of Confidence: Public Misinformation, Environmental Claims, and the Rise of AI-Generated Health Fraud

Nana Muazin August 21, 2026
Volume 52 | August 13, 2026 In an era defined by rapid technological advancement and a shifting...
Read More Read more about The Crisis of Confidence: Public Misinformation, Environmental Claims, and the Rise of AI-Generated Health Fraud
Data as a Lifeline: METAvivor Advocates for Robust 2027 Funding for National Cancer Registries data-as-a-lifeline-metavivor-advocates-for-robust-2027-funding-for-national-cancer-registries
  • Metastatic Breast Cancer Research

Data as a Lifeline: METAvivor Advocates for Robust 2027 Funding for National Cancer Registries

Laily UPN August 21, 2026
In the complex architecture of oncology research and public health, the most potent weapon is often not...
Read More Read more about Data as a Lifeline: METAvivor Advocates for Robust 2027 Funding for National Cancer Registries

Posts pagination

Previous 1 … 375 376 377 378 379 380 381 … 851 Next

Recent Posts

  • Revolutionizing Breast Cancer Screening: A New Era of Personalized Risk Assessment Emerges from the WISDOM Study
  • Breakthrough in ALS Treatment: Zhimeng Biopharma Completes Patient Enrollment for Pivotal CB03-154 Trial
  • Bridging the Gap: How Research and Innovation are Redefining the Breast Cancer Journey in Canada
  • Karyopharm Therapeutics Enters Chapter 11: A Strategic Auction Amidst Financial Crisis
  • FDA Approval of Inovio’s Voceryq: A Landmark for DNA Medicine Amidst Device Scrutiny

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

revolutionizing-breast-cancer-screening-a-new-era-of-personalized-risk-assessment-emerges-from-the-wisdom-study
  • Medical Research and Clinical Trials

Revolutionizing Breast Cancer Screening: A New Era of Personalized Risk Assessment Emerges from the WISDOM Study

Laily UPN November 2, 2026
breakthrough-in-als-treatment-zhimeng-biopharma-completes-patient-enrollment-for-pivotal-cb03-154-trial
  • Medical Research and Clinical Trials

Breakthrough in ALS Treatment: Zhimeng Biopharma Completes Patient Enrollment for Pivotal CB03-154 Trial

Ali Ikhwan November 2, 2026
bridging-the-gap-how-research-and-innovation-are-redefining-the-breast-cancer-journey-in-canada
  • Patient Advocacy and Support

Bridging the Gap: How Research and Innovation are Redefining the Breast Cancer Journey in Canada

Basiran November 2, 2026
karyopharm-therapeutics-enters-chapter-11-a-strategic-auction-amidst-financial-crisis
  • Chemotherapy and Targeted Therapy

Karyopharm Therapeutics Enters Chapter 11: A Strategic Auction Amidst Financial Crisis

Jia Lissa November 2, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.